Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

NCT00083213 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

BIOLOGICAL: ziv-aflibercept

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]